Company Analysis

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Nasdaq: CRBP · Pharmaceutical Preparations · Norwood, MA · filing with the SEC since 2014
Grade4.7
◀ Past 2.6● Present 5.1▶ Future 5.7
4 est.

Who runs Corbus Pharmaceuticals Holdings, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Cohen Yuval
Chief Executive Officer. First filing Nov 2014, latest Aug 10, 2026, 23 filings in all.
Officers reporting now
6
of 12 people with a filing in the last fifteen months
Directors reporting now
6
24 people on the record since 2014
Officerssales are open-market, Nov 2, 2025 to Nov 2, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Nicacio Leonardo VianaChief Medical OfficerAug 2026Aug 17, 2026none
Saxena Nishant CChief Business OfficerMay 2026Aug 12, 2026none
Cohen YuvalChief Executive OfficerNov 2014Aug 10, 20262 · $300,000
Moran Sean F.Chief Financial OfficerNov 2014Aug 10, 20262 · $200,000
Smethurst DominicChief Medical OfficerFeb 2024Mar 4, 20262 · $100,000
Hodgson IanChief Operating OfficerMar 2025Feb 18, 20262 · $0.00
Directorssales are open-market, Nov 2, 2025 to Nov 2, 2026
NameRoleFirst filingLatest filingSales, 12 months
Ben YongdirectorMar 2023Sep 15, 20261 · $0.00
Altmeyer AnnedirectorSep 2022Jun 11, 20261 · $0.00
Jenkins John KennethdirectorJun 2018Jun 11, 20261 · $0.00
Kung WinstondirectorAug 2024Jun 11, 20261 · $0.00
Jacques Rachelle SuzannedirectorApr 2019May 21, 2026none
Pfeiffenberger BrentdirectorMay 2026May 21, 2026none
Owners of more than 10% of a classsales are open-market, Nov 2, 2025 to Nov 2, 2026
NameRoleFirst filingLatest filingSales, 12 months
Chen Bihua10% ownerJan 2024Nov 2, 20261 · $300,000
Cormorant Asset Management, LP10% ownerJan 2024Nov 2, 20261 · $1.7M
Cormorant Global Healthcare Master Fund, LP10% ownerJan 2024Nov 2, 2026none
Earlier names on the record12, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton CRBP · research, not advice